Richard Anthony Cunningham - 09 Dec 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel George, Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
09 Dec 2024
Transactions value $
$0
Form type
4
Filing time
10 Dec 2024, 09:00:05 UTC
Previous filing
11 Oct 2023
Next filing
07 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +254,433 $0 254,433 09 Dec 2024 Common Stock 254,433 $1.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the options vest immediately on the date of the grant.